Otezla Clinical Trials
Here is the most popular medical study for otezla
Popular filter options for otezla trials
Phase 3 Clinical Trials
View 12 phase 3 medical studies.
Janus Kinase (JAK) Inhibitor
Deucravacitinib for Psoriatic Arthritis
Recruiting1 awardPhase 3
New York, New York
This trial will compare the safety and effectiveness of deucravacitinib to a placebo in people with active psoriatic arthritis who have never taken a biologic disease modifying antirheumatic drug or who have previously taken a TNFα inhibitor.
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
Clinical Trials With No Placebo
View 12 medical studies that do not have a placebo group.
Phosphodiesterase 4 (PDE4) Inhibitor
Long-Term Apremilast Use for Psoriasis
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial provides the option to continue apremilast treatment for up to 4 years for those who complete an initial 52-week trial. There will be an 8-week observational follow-up phase.
Phosphodiesterase 4 (PDE4) inhibitor
Apremilast for Psoriasis
Recruiting4 awardsPhase 4
Rockville, Maryland
Researchers want to find out if giving the drug Apremilast in combination with Clobetasol spray can help people clear their moderate to severe plaque psoriasis quicker than if Apremilast is used by itself.
Phosphodiesterase 4 (PDE4) Inhibitor
Apremilast for Frontal Fibrosing Alopecia
Recruiting4 awardsPhase 4
Bellevue, Washington
This is open label single side study involvement 20 patient treated with Apremilast. Each enrolled patient may be evaluated at by a dermatologist using the Lichen Planopilaris Activity Index and Frontal Fibrosing Alopecia Index. Other measures include physician global assessment, dermatology quality of life and patients analogue score for pruritus. Pt will have visits at Week 0,2,4,8,12,16,20,24
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.